• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植后附着点病和非典型痛风性关节炎:一项病例对照研究。

Enthesopathy and atypical gouty arthritis following renal transplantation: a case control study.

作者信息

Cohen M R, Cohen E P

机构信息

Department of Medicine, Medical College of Wisconsin, Milwaukee, USA.

出版信息

Rev Rhum Engl Ed. 1995 Feb;62(2):86-90.

PMID:7600077
Abstract

AIMS

To define associations and causative factors in a musculotendinous pain syndrome occurring after kidney transplantation.

METHODS

A case-control study was performed. Cases were identified clinically; transplant controls were matched for age, sex, date and type of transplant, and dialysis controls were matched for age, sex, and race.

RESULTS

All cases had enthesitis and five of seven later developed gouty arthritis. None of the controls had findings. The plasma uric acid was significantly greater in cases compared to both control groups.

CONCLUSIONS

A painful musculotendinous syndrome may occur after kidney transplantation. The development of gouty arthritis in five of the seven kidney transplant patients suffering from this syndrome and significant hyperuricemia compared with controls suggested an unusual pattern of gout arthropathy.

摘要

目的

确定肾移植后发生的肌腱疼痛综合征的关联因素和致病因素。

方法

进行了一项病例对照研究。通过临床诊断确定病例;移植对照组在年龄、性别、移植日期和类型方面进行匹配,透析对照组在年龄、性别和种族方面进行匹配。

结果

所有病例均有附着点炎,7例中有5例后来发展为痛风性关节炎。对照组均无相关发现。与两个对照组相比,病例组的血浆尿酸显著更高。

结论

肾移植后可能发生疼痛性肌腱综合征。7例患有该综合征的肾移植患者中有5例发生痛风性关节炎,且与对照组相比有明显的高尿酸血症,提示痛风性关节病的一种不寻常模式。

相似文献

1
Enthesopathy and atypical gouty arthritis following renal transplantation: a case control study.肾移植后附着点病和非典型痛风性关节炎:一项病例对照研究。
Rev Rhum Engl Ed. 1995 Feb;62(2):86-90.
2
[Polyarticular gout--change in the clinical picture?].[多关节痛风——临床表现有变化吗?]
Z Arztl Fortbild (Jena). 1996 May;90(3):227-31.
3
Does renal impairment protect from gout?肾功能损害能预防痛风吗?
J Rheumatol. 1995 Mar;22(3):494-6.
4
Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.通过降低血清尿酸水平的能力,使用别嘌醇来减缓肾脏疾病的进展。
Am J Kidney Dis. 2006 Jan;47(1):51-9. doi: 10.1053/j.ajkd.2005.10.006.
5
Juvenile gouty arthritis. Two cases associated with mild renal insufficiency.青少年痛风性关节炎。两例与轻度肾功能不全相关。
Am J Dis Child. 1984 Oct;138(10):955-7.
6
[Clinical studies on hyperuricemia and gout after transplantation].移植后高尿酸血症和痛风的临床研究
Hinyokika Kiyo. 1990 Aug;36(8):893-6.
7
Concomitant polyarticular septic and gouty arthritis.合并多关节化脓性和痛风性关节炎。
J Rheumatol. 2006 Aug;33(8):1707-8.
8
A study of uric acid metabolism and gouty arthritis in patients with polycystic kidney.多囊肾患者尿酸代谢与痛风性关节炎的研究
Nihon Jinzo Gakkai Shi. 1993 Jan;35(1):43-8.
9
[Therapeutic effect of hemodialysis on gouty arthritis and tophi in 2 patients with chronic renal failure].[血液透析对2例慢性肾衰竭患者痛风性关节炎及痛风石的治疗效果]
Nihon Jinzo Gakkai Shi. 1993 Jun;35(6):783-9.
10
Long-term cardiovascular mortality among middle-aged men with gout.中年痛风男性的长期心血管死亡率
Arch Intern Med. 2008 May 26;168(10):1104-10. doi: 10.1001/archinte.168.10.1104.

引用本文的文献

1
Succinic anhydride-based chemical modification making laccase@Cu(PO) hybrid nanoflowers robust in removing bisphenol A in wastewater.基于琥珀酸酐的化学修饰使漆酶@Cu(PO)杂化纳米花在去除废水中的双酚A方面具有稳定性。
Bioprocess Biosyst Eng. 2021 Oct;44(10):2061-2073. doi: 10.1007/s00449-021-02583-x. Epub 2021 May 13.
2
Gout and organ transplantation.痛风与器官移植。
Curr Rheumatol Rep. 2012 Apr;14(2):165-72. doi: 10.1007/s11926-012-0235-9.
3
Gout in solid organ transplantation: a challenging clinical problem.实体器官移植中的痛风:一个具有挑战性的临床问题。
Drugs. 2005;65(18):2593-611. doi: 10.2165/00003495-200565180-00004.
4
Enthesopathy and tendinopathy in gout: computed tomographic assessment.痛风中的附着点病和肌腱病:计算机断层扫描评估
Ann Rheum Dis. 1996 Dec;55(12):921-3. doi: 10.1136/ard.55.12.921.